Ascendis Pharma A (ASND) Change in Taxes (2014 - 2015)
Ascendis Pharma A (ASND) posted Change in Taxes of -$134586.5 for Q3 2015, down 109.97% sequentially from -$64098.2 in Q2 2015, and up 43.67% YoY from -$93679.4 in Q3 2014.
Powered by 
Analysis
Ascendis Pharma A (ASND) Change in Taxes (2014 - 2015) Analysis & Trends
Ascendis Pharma A has reported Change in Taxes for 2 years, with the latest figure at -$134586.5 in Q3 2015.
- Quarterly Change in Taxes rose 43.67% year-over-year to -$134586.5 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was -$990248.2 (changed N/A YoY) and the FY2014 annual result came in at -$1.1 million, down 234.61% from the prior year.
- Change in Taxes eased to -$134586.5 in Q3 2015 per ASND's latest filing, from -$64098.2 in the prior quarter.
- Over five years, Change in Taxes peaked at -$53444.3 in Q1 2014 and troughed at -$724903.4 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 16.39 Bn | 15.45 Bn | 362.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | -134,586.47 |
| Jun 30, 2015 | -64,098.19 |
| Mar 31, 2015 | -66,660.12 |
| Dec 31, 2014 | -724,903.42 |
| Sep 30, 2014 | -238,912.46 |
| Mar 31, 2014 | -53,444.25 |